Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements (NCT05637814)

🧪 Interventions in This Study

• SpO2/PIx Measurement and ML Algorithm (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (3 Sites)

• UC Davis Medical Center — Davis, California
• Cohen Children's Medical Center — Queens, New York
• University of Utah Health Care — Salt Lake City, Utah

📞 Contact the Study Coordinator

Phone: (916) 713-7697

Email: hsiefkes@ucdavis.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Congenital Heart Disease

• Technical Development for Pediatric Cardiovascular MRI — Washington D.C., District of Columbia
• Harmony TPV Post-Approval Study — Birmingham, Alabama
• The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study — Los Angeles, California
• Autus Valve Pivotal Study — Los Angeles, California
• Peer Coaching Intervention in Young Adults With Congenital Heart Disease — Durham, North Carolina
• SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure — Toronto, Ontario

Explore by condition: All Congenital Heart Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.